| Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. 5 A
Yang J et al. (2020)
|
Xla Wt + xbp1 MO
NF37/38 (in situ hybridization)
|
|
|
|
|
Fig, 5 B
Yang J et al. (2020)
|
Xla Wt + xbp1 MO
NF37/38 (RT-PCR)
|
|
|
|
Fig 1. L
Zhang Z et al. (2016)
|
Xla Wt + sdc4 MO
NF45 (in situ hybridization)
|
|
|
|
Fig. 5 C D
Yuan L et al. (2014)
|
Xla Wt + ern1 MO
NF 30
|
|
|
|
fig.2.i
Zhang Z et al. (2013)
|
Xla Wt + fzd7 MO
NF35/36 (in situ hybridization)
|
|
|
|
Fig 1B
Shifley ET et al. (2012)
|
Xla Wt + endoderm explant
NF37/38 (in situ hybridization)
|
|
|
|
|
Fig 1B
Shifley ET et al. (2012)
|
Xla Wt + endoderm explant
NF37/38 (in situ hybridization)
|
|
|
|
|
Fig 1B
Shifley ET et al. (2012)
|
Xla Wt + endoderm explant
NF37/38 (in situ hybridization)
|
|
|
|
|
Fig 1B
Shifley ET et al. (2012)
|
Xla Wt + endoderm explant
NF37/38 (in situ hybridization)
|
|
|
|
fig.3.a,c
Shifley ET et al. (2012)
|
Xla Wt + Mmu.fgfr1del-Mmu.fkbp1adel + B/B Homodimerizer
NF35/36 (in situ hybridization)
|
|
|